-The Hindu In order to address the multiple goals of fertilizer policy, India needs to work on four key areas Since 1991, when economic reforms began in India, several attempts have been made to reform the fertilizer sector to keep a check on the rising fertilizer subsidy bill, promote the efficient use of fertilizers, achieve balanced use of N, P, and K (nitrogen, phosphorus, and potassium), and reduce water and air pollution...
More »SEARCH RESULT
Total Matching Records found : 82
Now, sanitary pads for Rs 1 at Jan Aushadhis -Sushmi Dey
-The Times of India NEW DELHI: With an aim to ensure women’s hygiene, the government has slashed price of sanitary napkins sold at Jan Aushadhi stores to just Re 1 per piece from Rs 2.50. The biodegradable napkins - available in a pack of four - will be sold at a subsidized price under the brand 'Suvidha' at 5,500 such stores across the country. The move assumes significance as many women, especially...
More »Many essential drugs priced much higher than manufacturing cost: WHO -Sushmi Dey
-The Times of India NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows highlighting the “exorbitant” profiteering by pharmaceutical companies and the scope for lowering prices of drugs. While innovative and newer drugs for cancer, hepatitis C and rare diseases are out of reach of many due to their unaffordable prices,...
More »Private hospitals making profits of up to 1,737% on drugs, consumables and diagnostics: Study -Rema Nagarajan
-The Times of India NEW DELHI: An analysis of bills from four reputed private hospitals in Delhi and NCR by the National Pharmaceutical Pricing Authority (NPPA) has revealed that they are making profits of up to 1,737% on drugs, consumables and diagnostics and that these three accounts for about 46% of a patient’s bill. The analysis, released on Tuesday, noted that “the major beneficiaries of profits in all these cases because of...
More »Consumables now costlier than stents in angioplasty -Rema Nagarajan
-The Times of India NEW DELHI: Even as stent prices have been capped, the cost of the three main consumables used in angioplasty have, in many cases, become even more expensive than stents as hospitals try to make up for the huge margins they lost on stents. The modus operandi is same as in the case of stents before the price cap. Though the consumables are bought at a third or less...
More »
